Molbio Diagnostics reported a consolidated profit of ₹58.7 crore for the quarter, a significant improvement from the ₹23.7 crore loss recorded in the same period last year. Revenue also quadrupled to ₹408.4 crore from ₹99.7 crore. The company was among the key stocks in focus at the start of Monday’s trading session amid weak global cues.